Saram ConsultingGxP & AI Consulting for Life Sciences. Custom AI integrations, Part 11 compliance validation, and equity-based engineering partnerships for biotech.Explore Services at saram.io →
← Back to Home

Adecto Pharmaceuticals

Private
#Oncology#Antibodies#Diagnostics

Preclinical-stage oncology biotechnology company developing antibody therapeutics and diagnostics targeting the ADAM8 cell-surface protein, a driver of multiple aggressive cancers.

Company Info

Sector:Biotechnology
Headquarters:Boston, Massachusetts, USA
Founded:2014
Website:www.adectopharma.com/

Clinical Development Pipeline

ADAM8 metalloproteinase-domain antibodies

Target: ADAM8
Primary and metastatic solid tumors
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Anti-ADAM8 monoclonal antibody panel

Target: ADAM8
Translational research in aggressive cancers
Preclinical
Phase 1
Phase 2
Phase 3
Approved

ADAM8 diagnostic assays

Target: ADAM8
Cancer detection and patient selection
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Recent News

Leadership Team

Nora Mineva

Chief Executive Officer & Co-Founder

Gail E. Sonenshein

Co-Founder & President

Careers & Job Openings

See all open roles

All
Boston, Massachusetts, USA
Apply Now →